Literature DB >> 8627076

J774 murine macrophage-like cell interactions with Cryptococcus neoformans in the presence and absence of opsonins.

S Mukherjee1, M Feldmesser, A Casadevall.   

Abstract

The interaction of Cryptococcus neoformans with the murine macrophage-like cell line J774.16 was studied in the presence and absence of monoclonal antibodies (MAbs) to the capsular polysaccharide glucuronoxylomannan (GXM). In the absence of MAb 2H1 to GXM, coincubation of J774.16 cells with C. neoformans reduced fungal colony-forming units in only 26.6% of 21 independent experiments. In the presence of MAb 2H1, coincubation of J774.16 cells with C. neoformans reduced fungal colony-forming units in > 95% of experiments. Comparison of the relative efficacy of two IgG1 MAbs revealed that the higher affinity MAb was more effective at low concentrations. Antibody-mediated reductions of C. neoformans colony-forming units by J774.16 cells occurred despite inhibition of nitric oxide synthase, addition of reactive oxygen intermediate scavengers, or the use of a superoxide-deficient J774 mutant line.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8627076     DOI: 10.1093/infdis/173.5.1222

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  29 in total

1.  An In Vitro Model for the Study of the Macrophage Response Upon Trichophyton rubrum Challenge.

Authors:  Fabio Seiti Yamada Yoshikawa; Lucas Gonçalves Ferreira; Fernando Gonçalves de Almeida; Sandro Rogerio de Almeida
Journal:  Mycopathologia       Date:  2016-10-14       Impact factor: 2.574

2.  Roles for inositol-phosphoryl ceramide synthase 1 (IPC1) in pathogenesis of C. neoformans.

Authors:  C Luberto; D L Toffaletti; E A Wills; S C Tucker; A Casadevall; J R Perfect; Y A Hannun; M Del Poeta
Journal:  Genes Dev       Date:  2001-01-15       Impact factor: 11.361

Review 3.  Macrophages in resistance to candidiasis.

Authors:  A Vázquez-Torres; E Balish
Journal:  Microbiol Mol Biol Rev       Date:  1997-06       Impact factor: 11.056

4.  Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis.

Authors:  Robert A Larsen; Peter G Pappas; John Perfect; Judith A Aberg; Arturo Casadevall; Gretchen A Cloud; Robert James; Scott Filler; William E Dismukes
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

5.  Replication of Cryptococcus neoformans in macrophages is accompanied by phagosomal permeabilization and accumulation of vesicles containing polysaccharide in the cytoplasm.

Authors:  Stephanie C Tucker; Arturo Casadevall
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-05       Impact factor: 11.205

6.  Protection against cryptococcosis by using a murine gamma interferon-producing Cryptococcus neoformans strain.

Authors:  Floyd L Wormley; John R Perfect; Chad Steele; Gary M Cox
Journal:  Infect Immun       Date:  2007-01-08       Impact factor: 3.441

7.  Isotype switching increases efficacy of antibody protection against Cryptococcus neoformans infection in mice.

Authors:  R R Yuan; G Spira; J Oh; M Paizi; A Casadevall; M D Scharff
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

8.  Receptor-mediated phagocytosis of rat macrophages is regulated differentially for opsonized particles and non-opsonized particles containing beta-glucan.

Authors:  J S Reichner; P A Fitzpatrick; E Wakshull; J E Albina
Journal:  Immunology       Date:  2001-10       Impact factor: 7.397

9.  Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies.

Authors:  A Casadevall; W Cleare; M Feldmesser; A Glatman-Freedman; D L Goldman; T R Kozel; N Lendvai; J Mukherjee; L A Pirofski; J Rivera; A L Rosas; M D Scharff; P Valadon; K Westin; Z Zhong
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

10.  Dependence of macrophage phagocytic efficacy on antibody concentration.

Authors:  Natasa Macura; Tong Zhang; Arturo Casadevall
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.